Nina L Fowler1, Ian H Frazer. 1. Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Abstract
OBJECTIVE: To determine whether squamous cervical cancers exhibit mutations or deletions in MHC class I genes or transport-associated protein (TAP) genes. METHODS: Polymerase chain reaction based protocols were used to examine HLA class I and TAP genes in a panel of cervical tumours, using DNA from corresponding blood samples as controls. SSP-PCR protocols were similarly used for examination of all TAP alleles in tumour and blood samples. RESULTS: In a series of cervical carcinomas, 7 of 27 (26%) exhibited mutations in HLA-A genes, while 12 of 23 (52%) exhibited mutations in TAP genes. HLA gene mutations were detected in 2 of 14 CIN2-3 lesions, and TAP gene mutations in none of 14, a frequency significantly less than observed in the cervical carcinoma samples (P<0.01). The TAP 2A/2B heterozygous genotype was observed with increased frequency in patients with cervical cancer compared to population controls (P<0.02). CONCLUSION: These data suggest that TAP genes may be relevant to evolution of cervical cancer from precursor lesions.
OBJECTIVE: To determine whether squamous cervical cancers exhibit mutations or deletions in MHC class I genes or transport-associated protein (TAP) genes. METHODS: Polymerase chain reaction based protocols were used to examine HLA class I and TAP genes in a panel of cervical tumours, using DNA from corresponding blood samples as controls. SSP-PCR protocols were similarly used for examination of all TAP alleles in tumour and blood samples. RESULTS: In a series of cervical carcinomas, 7 of 27 (26%) exhibited mutations in HLA-A genes, while 12 of 23 (52%) exhibited mutations in TAP genes. HLA gene mutations were detected in 2 of 14 CIN2-3 lesions, and TAP gene mutations in none of 14, a frequency significantly less than observed in the cervical carcinoma samples (P<0.01). The TAP 2A/2B heterozygous genotype was observed with increased frequency in patients with cervical cancer compared to population controls (P<0.02). CONCLUSION: These data suggest that TAP genes may be relevant to evolution of cervical cancer from precursor lesions.
Authors: Mark H Einstein; Suzanne Leanza; Lydia G Chiu; Nicolas F Schlecht; Gary L Goldberg; Bettie M Steinberg; Robert D Burk Journal: Clin Cancer Res Date: 2009-02-01 Impact factor: 12.531
Authors: Dor Mohammad Kordi Tamandani; Ranbir Chander Sobti; Mohammad Shekari; Seyd Ali Husseini; Vanita Suri Journal: J Assist Reprod Genet Date: 2009-03-05 Impact factor: 3.412
Authors: Camilla Natter; Stephan Polterauer; Jasmin Rahhal-Schupp; Dan Cacsire Castillo-Tong; Sophie Pils; Paul Speiser; Robert Zeillinger; Georg Heinze; Christoph Grimm Journal: Dis Markers Date: 2013-07-28 Impact factor: 3.434